As of June 30, 2026, NEW RAY MEDICINE INTL HLDG LTD carries a market capitalization of 41.33M, placing it among publicly traded companies globally. Its enterprise value stands at -30.13M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 41.33M |
| Enterprise Value | -30.13M |
As of June 30, 2026, NEW RAY MEDICINE INTL HLDG LTD has 200.62M shares outstanding.
| Shares Outstanding | 200.62M |
These figures are as of June 30, 2026.
| PB Ratio | 0.09 |
| P/TBV Ratio | 0.09 |
As of June 30, 2026, NEW RAY MEDICINE INTL HLDG LTD maintains a current ratio of 11.65, meaning it holds 11.7x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 11.65 |
| Quick Ratio | 2.49 |
| Debt / Equity | 0.49 |
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 31.00 |
As of the close on November 17, 2026, NEW RAY MEDICINE INTL HLDG LTD's stock has declined approximately 1.64% over the past 52 weeks. The 50-day moving average sits at 0.26, while the 200-day moving average is 0.23.
| 52-Week Price Change | -1.64% |
| 50-Day Moving Average | 0.26 |
| 200-Day Moving Average | 0.23 |
As of June 30, 2026, NEW RAY MEDICINE INTL HLDG LTD holds 73.58M in cash and equivalents against 2.12M in total debt, resulting in a net debt position of -73.58M. Total book value stands at 435.85M, with working capital of 314.59M providing operational flexibility.
| Cash & Cash Equivalents | 73.58M |
| Total Debt | 2.12M |
| Net Debt | -73.58M |
| Equity (Book Value) | 435.85M |
| Book Value Per Share | 2.17 |
| Working Capital | 314.59M |
NEW RAY MEDICINE INTL HLDG LTD's most recent stock split took place on August 5, 2025 with a 10:1 split ratio.
| Last Split Date | 8/5/2025 |
| Split Ratio | 10:1 |
Already premium?